Wen et al. (2016) demonstrated that solanine treatment suppresses vascular endothelial growth factor expression in human pancreatic cancer cells by down-regulating the ERK1/2-HIF-1α and STAT3 signaling pathways [38]. The gene discussed is STAT3; the disease is familial pancreatic carcinoma.